Sales forecast of select blockbuster drugs by Novartis worldwide 2028
In 2028, Novartis blockbuster drug Cosentyx is projected to generate some 7.1 billion U.S. dollars in sales worldwide, while drug Entrestro is forecasted to generate around 6.3 billion U.S. dollars globally in the same year. This statistic illustrates the sales forecast of select of Novartis' blockbuster drugs worldwide in 2028.